Alpha 2.0
Login Register
» Articles » PMID: 18979266

Motesanib Diphosphate (AMG 706), an Oral Angiogenesis Inhibitor, Demonstrates Clinical Efficacy in Advanced Thymoma

Overview
Journal Acta Oncol
Specialty Oncology
Date 2008 Nov 4
PMID 18979266
Citations 8
Authors
Arun Azad
Rebecca A Herbertson
David Pook
Shane White
Paul L R Mitchell
Niall C Tebbutt
Affiliations
Soon will be listed here.
Citing Articles

S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma.

Tsao A, Hsieh M, Koczywas M, Tu J, Riess J, Tanvetyanon T JTO Clin Res Rep. 2024; 5(12):100738.

PMID: 39619274 PMC: 11605468. DOI: 10.1016/j.jtocrr.2024.100738.

Immunotherapy and Targeted Therapies Efficacy in Thymic Epithelial Tumors: A Systematic Review.

Agrafiotis A, Brandao M, Berghmans T, Durieux V, Jungels C Biomedicines. 2023; 11(10).

PMID: 37893096 PMC: 10604659. DOI: 10.3390/biomedicines11102722.

[Treatment of Recurrent Thymoma].

Liu X, Li X, Li J Zhongguo Fei Ai Za Zhi. 2020; 23(3):204-210.

PMID: 32102138 PMC: 7118328. DOI: 10.3779/j.issn.1009-3419.2020.03.11.

The clinical features, diagnosis and management of recurrent thymoma.

Luo T, Zhao H, Zhou X J Cardiothorac Surg. 2016; 11(1):140.

PMID: 27580949 PMC: 5007840. DOI: 10.1186/s13019-016-0533-9.

Thymic neoplasm: a rare disease with a complex clinical presentation.

Rashid O, Cassano A, Takabe K J Thorac Dis. 2013; 5(2):173-83.

PMID: 23585946 PMC: 3621939. DOI: 10.3978/j.issn.2072-1439.2013.01.12.